Dr. Constanze Helbig is a working as Senior Scientist at Coriolis Pharma, a science-driven contract research organization located in Munich, Germany, for formulation development, lyophilization, and analytics of biopharmaceuticals and ATMPs. She is a biophysicist by training and received her PhD from the Medical Department of the University of Munich. At Coriolis Pharma, she is responsible for the scientific evaluation and implementation of novel methods and strategies for developability assessment and particle analysis in biopharmaceuticals.